169 related articles for article (PubMed ID: 31133447)
21. Percutaneous sclerotherapy for spongiform venous malformations - analysis of patient-evaluated outcome and satisfaction.
Clemens RK; Baumann F; Husmann M; Meier TO; Thalhammer C; MacCallum G; Amann-Vesti BR; Alomari AI
Vasa; 2017 Oct; 46(6):477-483. PubMed ID: 28841126
[TBL] [Abstract][Full Text] [Related]
22. Patient satisfaction after sclerotherapy of venous malformations in children.
Nakahata K; Uehara S; Zenitani M; Nakamura M; Osuga K; Okuyama H
Pediatr Int; 2016 Aug; 58(8):721-5. PubMed ID: 26662951
[TBL] [Abstract][Full Text] [Related]
23. Sclerotherapy for simple cysts with use of ethanolamine oleate: preliminary experience.
Yamamoto K; Sakaguchi H; Anai H; Tanaka T; Morimoto K; Kichikawa K; Uchida H
Cardiovasc Intervent Radiol; 2005; 28(6):751-5. PubMed ID: 16132390
[TBL] [Abstract][Full Text] [Related]
24. Sclerotherapy for Venous Malformations of the Pharynx or the Tongue Base Without Tracheostomy: Treatment Protocol With Intubation and Outcomes.
Iwashina Y; Ozaki M; Wong M; Ihara A; Fujiki M; Takushima A; Harii K
J Craniofac Surg; 2020; 31(3):702-706. PubMed ID: 32149978
[TBL] [Abstract][Full Text] [Related]
25. Craniofacial cavernous venous malformations: percutaneous sclerotherapy with use of ethanolamine oleate.
Choi YH; Han MH; O-Ki K; Cha SH; Chang KH
J Vasc Interv Radiol; 2002 May; 13(5):475-82. PubMed ID: 11997355
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of ethanolamine oleate sclerotherapy on the submandibular glands of canines as a potential therapy for sialorrhea.
Abbas F; Farid R; Nada I; El-Sharnouby M
Int J Pediatr Otorhinolaryngol; 2013 Mar; 77(3):351-5. PubMed ID: 23246419
[TBL] [Abstract][Full Text] [Related]
27. Pulsed dye laser-resistant capillary malformation treated using intradermal sclerotherapy with ethanolamine oleate after intense pulsed light treatment.
Hwang SW; Lee HJ; Hong SK; Seo JK; Lee D; Sung H
Dermatol Surg; 2010 Nov; 36(11):1775-8. PubMed ID: 20868377
[No Abstract] [Full Text] [Related]
28. Experience with 5% ethanolamine oleate for sclerotherapy of oral vascular anomalies: A cohort of 15 consecutive patients.
Kato CNAO; Ribeiro MC; do Amaral MBF; Grossmann SMC; de Aguiar MCF; Mesquita RA
J Craniomaxillofac Surg; 2019 Jan; 47(1):106-111. PubMed ID: 30527382
[TBL] [Abstract][Full Text] [Related]
29. [Experimental studies on respiratory insufficiency after endoscopic injection sclerotherapy using ethanolamine-oleate].
Umekita N
Nihon Geka Gakkai Zasshi; 1986 Feb; 87(2):172-9. PubMed ID: 3713671
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness and safety of foam sclerotherapy with 5% ethanolamine oleate in the treatment of low-flow venous malformations in the head and neck region: a case series.
Ribeiro MC; de Mattos Camargo Grossmann S; do Amaral MBF; de Castro WH; Navarro TP; Procopio RJ; da Silva TA; de Nazaré Alves de Oliveira Kato C; Mesquita RA
Int J Oral Maxillofac Surg; 2018 Jul; 47(7):900-907. PubMed ID: 29329829
[TBL] [Abstract][Full Text] [Related]
31. [Disturbances of pulmonary gas exchange after sclerotherapy for esophageal varices].
Rusiniak K; Szczepanik AB; Ratajczak J; Meissner AJ
Wiad Lek; 1997; 50 Suppl 1 Pt 1():298-302. PubMed ID: 9446371
[TBL] [Abstract][Full Text] [Related]
32. Five adult laryngeal venous malformation cases treated effectively with sclerotherapy.
Kamijo A; Hatsushika K; Kanemaru S; Moriyama M; Kase Y; Masuyama K
Laryngoscope; 2013 Nov; 123(11):2766-9. PubMed ID: 23553378
[TBL] [Abstract][Full Text] [Related]
33. Sclerotherapy complications of peripheral venous malformations.
Aronniemi J; Castrén E; Lappalainen K; Vuola P; Salminen P; Pitkäranta A; Pekkola J
Phlebology; 2016 Dec; 31(10):712-722. PubMed ID: 26494223
[TBL] [Abstract][Full Text] [Related]
34. Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy.
Tatemichi M; Nagata H; Sekizuka E; Morishita T; Miyairi M; Tsuchiya M; Ishii H
Dig Dis Sci; 1996 Mar; 41(3):562-70. PubMed ID: 8617137
[TBL] [Abstract][Full Text] [Related]
35. Treatment of venous malformations with ethanolamine oleate: a descriptive study of 83 cases.
Hoque S; Das BK
Pediatr Surg Int; 2011 May; 27(5):527-31. PubMed ID: 21290138
[TBL] [Abstract][Full Text] [Related]
36. Detrimental influences of intraluminally-administered sclerotic agents on surrounding tissues and peripheral nerves: an experimental study.
Fujiki M; Kurita M; Ozaki M; Kawakami H; Kaji N; Takushima A; Harii K
J Plast Surg Hand Surg; 2012 Sep; 46(3-4):145-51. PubMed ID: 22686430
[TBL] [Abstract][Full Text] [Related]
37. Sclerotherapy as an esthetic indication in oral vascular malformations: a case series.
Manzano BR; Premoli AM; Santaella NG; Ikuta CRS; Rubira CMF; Santos PSDS
An Bras Dermatol; 2019; 94(5):521-526. PubMed ID: 31777351
[TBL] [Abstract][Full Text] [Related]
38. Ethanolamine oleate sclerotherapy combined with transarterial embolization using n-butyl cyanoacrylate for extracranial arteriovenous malformations.
Kitagawa A; Izumi Y; Hagihara M; Kamei S; Ikeda S; Katsuda E; Kimura J; Ota T; Ishiguchi T
Cardiovasc Intervent Radiol; 2014 Apr; 37(2):371-80. PubMed ID: 23737022
[TBL] [Abstract][Full Text] [Related]
39. Percutaneous sclerotherapy with ethanolamine oleate for lymphatic malformations of the head and neck.
Alexander MD; McTaggart RA; Choudhri OA; Marcellus ML; Do HM
J Neurointerv Surg; 2014 Nov; 6(9):691-4. PubMed ID: 24153336
[TBL] [Abstract][Full Text] [Related]
40. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
